SPRY
ARS Pharmaceuticals, Inc
4.10$
-1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | -69.1% | -76.1% | -97.7% | +297,063.3% | -5.5% | |
| – | +8.9% | +810.1% | -98.5% | +7,937.6% | -99.6% | +28,060.3% | -0.7% | |
| – | – | – | +40.6% | -398.6% | – | +228,540.0% | -6.9% | |
| – | +45.3% | -34.6% | +44.1% | -9.4% | +10.3% | -3.4% | -32.7% | |
| – | – | – | +10.7% | +293.8% | +156.2% | +51.6% | +221.1% | |
| – | +33.3% | -81.2% | +484.5% | -20.3% | +242.7% | +6.1% | +239.5% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | +265.5% | +686.8% | – | – | – | |
| – | – | – | – | – | – | – | -2,168.3% | |
| – | – | – | – | – | – | – | -127.8% | |
| – | – | – | – | – | – | – | -2,241.8% | |
| – | – | – | – | – | – | – | -2,101.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.